Vascular Protective Effects of Angiotensin Converting Enzyme Inhibitors and their Relation to Clinical Events

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2001-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00005344-200109011-00004PMID 11392475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic-pharmacodynamic (PK-PD) modeling for a new antihypertensive agent (neutral metalloendopeptidase inhibitor SCH 42354) in patients with mild to moderate hypertension

  2004cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS

  2000cited by this paper
• Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-Témoins sur l'Infarctus du Myocarde (ECTIM) Study.

  1999cited by this paper
• Basal nitric oxide production is impaired in offspring of patients with essential hypertension.

  1999cited by this paper
• Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade.

  1999cited by this paper
• The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people.

  1999cited by this paper
• Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension.

  1999cited by this paper
• Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

  1999cited by this paper
• Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo.

  1999cited by this paper
• Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients.

  1999cited by this paper
• Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension.

  1999cited by this paper
• ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.

  1998cited by this paper
• Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.

  1998cited by this paper
• Acute hypertension impairs endothelium-dependent vasodilation.

  1998cited by this paper
• Effects of omapatrilat in low, normal, and high renin experimental hypertension.

  1998cited by this paper
• Effects of antihypertensive agents on endothelial dysfunction: rationale for the brachial artery normalization of forearm function study.

  1998cited by this paper
• Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells.

  1998cited by this paper
• Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease.

  1998cited by this paper
• ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension

  1998cited by this paper
• Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function.

  1998cited by this paper
• Endothelial function and common carotid artery wall thickening in patients with essential hypertension.

  1998cited by this paper
• Effects of angiotensin converting enzyme inhibition on endothelium‐dependent vasodilatation in essential hypertensive patients

  1998cited by this paper
• Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.

  1998cited by this paper
• Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension

  1997cited by this paper
• Cardiopulmonary effects of endothelin-1 in man.

  1997cited by this paper
• Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats.

  1997cited by this paper
• Basal nitric oxide synthesis in essential hypertension.

  1997cited by this paper
• Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study.

  1997cited by this paper
• Hypertension causes premature aging of endothelial function in humans.

  1997cited by this paper
• Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension. TRACE Study Group, Trandolapril Cardiac Event.

  1997cited by this paper
• In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors.

  1996cited by this paper
• Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension.

  1996cited by this paper
• Menopause is associated with endothelial dysfunction in women.

  1996cited by this paper
• Effects of cilazapril on vascular structure and function in essential hypertension.

  1996cited by this paper
• Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.

  1996cited by this paper
• Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

  1996cited by this paper
• Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction)

  1996cited by this paper
• Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function.

  1995cited by this paper
• Aging and endothelial function in normotensive subjects and patients with essential hypertension.

  1995cited by this paper
• Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P.

  1995cited by this paper
• Close relation of endothelial function in the human coronary and peripheral circulations.

  1995cited by this paper
• Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.

  1995cited by this paper
• Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium

  1995cited by this paper
• The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction.

  1995cited by this paper
• Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity

  1995cited by this paper
• Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta.

  1995cited by this paper
• Combined renal effects of overweight and hypertension.

  1995cited by this paper
• Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

  1995cited by this paper
• Genetic Variability of the ET‐1 and the ETA Receptor Genes in Essential Hypertension

  1995cited by this paper
• Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

  1995cited by this paper
• Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells.

  1995cited by this paper
• Contrasting effect of antihypertensive treatment on the renal response to L-arginine.

  1995cited by this paper
• Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment

  1995cited by this paper
• Endothelin-converting Enzyme-2 Is a Membrane-bound, Phosphoramidon-sensitive Metalloprotease with Acidic pH Optimum (*)

  1995cited by this paper
• Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin.

  1995cited by this paper
• The endothelium in hypertension: bystander, target or mediator?

  1994cited by this paper
• Generation by the phosphoramidon‐sensitive peptidases, endopeptidase‐24.11 and thermolysin, of endothelin‐1 and C‐terminal fragment from big endothelin‐1

  1994cited by this paper
• Antihypertensive effects of the neutral endopeptidase inhibitor SCH 42495 in essential hypertension.

  1994cited by this paper
• Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats.

  1994cited by this paper
• The endothelium and cardiovascular disease--a complex relation.

  1994cited by this paper
• Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.

  1994cited by this paper
• Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats.

  1994cited by this paper
• Effect of potassium on vasodilation to acetylcholine in essential hypertension.

  1994cited by this paper
• Effect of captopril and enalapril on endothelial function in hypertensive patients.

  1994cited by this paper
• Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells.

  1994cited by this paper
• Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level.

  1994cited by this paper
• Spinal Cord Infarcts During Long‐term Inhibition of Nitric Oxide Synthase in Rats

  1994cited by this paper
• Angiotensin Blockade or Calcium Antagonists Improve Endothelial Dysfunction in Hypertension: Studies in Perfused Mesenteric Resistance Arteries

  1994cited by this paper
• ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1.

  1994cited by this paper
• Purification and characterization of endothelin-converting enzyme from rat lung.

  1993cited by this paper
• Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.

  1993cited by this paper
• The endothelium as a target and mediator of cardiovascular disease

  1993cited by this paper
• Role of Endothelium‐Derived Nitric Oxide in the Abnormal Endothelium‐Dependent Vascular Relaxation of Patients With Essential Hypertension

  1993cited by this paper
• Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.

  1993cited by this paper
• Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. OFF.

  1993cited by this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cited by this paper
• Impaired Endothelium‐Dependent Vasodilation in Patients With Insulin‐Dependent Diabetes Mellitus

  1993cited by this paper
• Renal and hormonal effects of chronic inhibition of neutral endopeptidase (EC 3.4.24.11) in normal man.

  1993cited by this paper
• Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex.

  1993cited by this paper
• Hypertension and Left Ventricular Hypertrophy Are Associated With Impaired Endothelium‐Mediated Relaxation in Human Coronary Resistance Vessels

  1993cited by this paper
• Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.

  1993cited by this paper
• Effect of Increased Availability of Endothelium‐Derived Nitric Oxide Precursor on Endothelium‐Dependent Vascular Relaxation in Normal Subjects and in Patients With Essential Hypertension

  1993cited by this paper
• Isoforms of nitric oxide synthase: functions in the cardiovascular system.

  1993cited by this paper
• Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11.

  1993cited by this paper
• Is endothelin involved in the pathogenesis of hypertension?

  1993cited by this paper
• Vasodilation to acetylcholine in primary and secondary forms of human hypertension.

  1993cited by this paper
• Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension.

  1993cited by this paper
• Different effects of angiotensin-converting enzyme inhibition in human arteries and veins.

  1993cited by this paper
• Endothelium‐Dependent Relaxations Are Augmented in Rats Chronically Treated with the Angiotensin‐Converting Enzyme Inhibitor Enalapril

  1992cited by this paper
• The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids

  1992cited by this paper
• Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide.

  1992cited by this paper
• Endothelium‐Dependent Forearm Vasodilation Is Reduced in Normotensive Subjects with Familial History of Hypertension

  1992cited by this paper
• The vascular endothelium in diabetes and hypertension.

  1992cited by this paper
• Immunoreactive circulating endothelin‐1 in normal and hypertensive pregnancies

  1992cited by this paper
• Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium.

  1992cited by this paper
• Local Potentiation of Bradykinin‐Induced Vasodilation by Converting‐Enzyme Inhibition in Isolated Coronary Arteries

  1992cited by this paper
• Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.

  1992cited by this paper
• Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.

  1992cited by this paper

• Special Issue “Zebrafish: A Model Organism for Human Health and Disease”

  2025cites this paper
• Metabolites Isolated from Senecio nutans Sch. Bip and Their Synthesized Oximes Inhibit Angiotensin I-Converting Enzyme Activity in Vascular Smooth Muscle

  2025cites this paper
• Relevance of Lipoprotein Composition in Endothelial Dysfunction and the Development of Hypertension

  2025cites this paper
• SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system

  2024cites this paper
• Alkaloids as Vasodilator Agents: a Review.

  2023cites this paper
• Enzyme de conversion de l’angiotensine

  2023cites this paper
• Therapeutic Advances in Patients with Heart Failure with Reduced Ejection Fraction Who Have Had a Previous Worsening Heart Failure Event

  2020cites this paper
• Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2

  2020cites this paper
• Nonrespiratory Functions of the Lung

  2019cites this paper
• Chronic ACE inhibitor therapy differently modulates mediators of endothelium- dependent dilation in small renal and mesenteric arteries. Effect of dietary sodium restriction

  2018cites this paper
• Age Aspects of Cardiovascular Disease

  2017influential citation
• Effects of NWT-03, an egg-protein hydrolysate, on blood pressure in normotensive, high-normotensive and mild-hypertensive men and women: a dose-finding study.

  2017cites this paper
• Effect of angiotensin-converting enzyme inhibitors on vascular endothelial function in hypertensive patients after intensive periodontal treatment.

  2016cites this paper
• Active components from Radix Scrophulariae inhibits the ventricular remodeling induced by hypertension in rats

  2016cites this paper
• Post-bleaching sensitivity in patients with sickle cell disease.

  2016cites this paper
• Critical insights into the beneficial and protective actions of the kallikrein-kinin system.

  2015cites this paper
• Phosphate Binding Reduces Aortic Angiotensin-Converting Enzyme and Enhances Nitric Oxide Bioactivity in Experimental Renal Insufficiency

  2014cites this paper
• Thirty-day mortality risk associated with the postoperative nonresumption of angiotensin-converting enzyme inhibitors: a retrospective study of the Veterans Affairs Healthcare System.

  2014cites this paper
• Inhibition of the renin-angiotensin system for lowering coronary artery disease risk.

  2013cites this paper
• Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature

  2013cites this paper
• The involvement of modified lipids in vascular injury and disease

  2013cites this paper
• Association between Chronic Blood Pressure Changes and Development of Alzheimer's Disease

  2012influential citation
• Sexual dimorphism in endothelin-1 induced mechanical hyperalgesia in the rat.

  2012cites this paper
• Nitric oxide: Orchestrator of endothelium-dependent responses

  2012cites this paper
• Attenuation of Renovascular Damage in Zucker Diabetic Fatty Rat by NWT-03, an Egg Protein Hydrolysate with ACE- and DPP4-Inhibitory Activity

  2012cites this paper
• The Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway"

  2011cites this paper
• Nonrespiratory Functions of the Lung

  2011cites this paper
• Enalapril improves endothelial function in patients with migraine: A randomized, double-blind, placebo-controlled trial

  2011cites this paper
• High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity.

  2011cites this paper
• Effect of chronic angiotensin converting enzyme inhibitor therapy on myocardial injury in patients undergoing percutaneous coronary interventions.

  2011cites this paper
• Clinical Exercise Physiology FOREARM BLOOD FLOW IN INDIVIDUALS WITH CHF AND AGE-MATCHED HEALTHY VOLUNTEERS: A STUDY AND HISTORICAL REVIEW

  2011influential citation
• Stabilizing unstable plaque in acute coronary syndromes

  2011cites this paper
• Plaque Passivation and Endothelial Therapy

  2011cites this paper
• The Endothelium, Part I: Multiple Functions of the Endothelial Cells -- Focus on Endothelium-Derived Vasoactive Mediators

  2011cites this paper
• Effects of Blood Pressure Changes on Alzheimer’s Disease

  2010cites this paper
• Enalapril prevents cardiac immune‐mediated damage and exerts anti‐Trypanosoma cruzi activity during acute phase of experimental Chagas disease

  2010cites this paper
• Anjiyoplasti ve Stent / Prevention of Ischemic Stroke : Antiplatelet Agents , Carotid Endarterectomy and Angioplasty and Stenting

  2009cites this paper
• Secondary prevention of atherothrombotic events after ischemic stroke.

  2009cites this paper
• Angiotensin-Converting Enzyme as a Potential Target for Treatment of Alzheimer's Disease: Inhibition or Activation?

  2008cites this paper
• Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heart

  2008cites this paper
• Intracoronary enalaprilat during angioplasty for acute myocardial infarction: alleviation of postischaemic neurohumoral and inflammatory stress?

  2007cites this paper
• Chronic pretreatment of ACEI reduces no‐reflow in patients with acute myocardial infarction treated with primary angioplasty

  2007cites this paper
• FOREARM BLOOD FLOW IN INDIVIDUALS WITH CHF AND AGE-MATCHED HEALTHY VOLUNTEERS: A STUDY AND HISTORICAL REVIEW

  2007cites this paper
• Enzyme de conversion de l'angiotensine

  2006cites this paper
• Inhibicí angiotensin konvertujícího enzymu k příznivému ovlivnění funkce endotelu a snížení kardiovaskulární morbidity a mortality

  2005cites this paper
• Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects.

  2005cites this paper
• Sodium intake and therapy resistance to ACE inhibition

  2005cites this paper
• Low Sodium Modifies the Vascular Effects of Angiotensin-Converting Enzyme Inhibitor Therapy in Healthy Rats

  2004cites this paper
• Angiotensin Receptor Blockade Decreases Markers of Vascular Inflammation

  2004cites this paper
• Changes of Tissue Endothelin-1 and Nitric Oxide Synthase in a Sheep Model of Large Intestinal Obstruction

  2004cites this paper
• BENEFICIAL EFFECTS OF QUINAPRILAT ON CORONARY VASOMOTOR FUNCTION, ENDOTHELIAL OXIDATIVE STRESS, AND ENDOTHELIN ACTIVATION AFTER HUMAN HEART TRANSPLANTATION

  2004influential citation
• Angiotensin AT1 receptor signal transduction

  2004cites this paper
• Different effects of antihypertensive drugs on endothelial dysfunction

  2004cites this paper
• Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle.

  2004cites this paper
• Effects of Endothelin Receptor Antagonist on Expression of AT1 and AT2 Receptors in the Heart of SHR-SP

  2004cites this paper
• Modulation de la biodisponibilité du monoxyde d'azote (no) en physiopathologie vasculaire : intérêt des stocks mobilisables de no et des antioxydants naturels

  2004cites this paper
• blood pressure in adult SHR by shifting the perinatal balance of NO and reactive oxygen species towards NO : the inverted Barker phenomenon

  2004cites this paper
• Perindopril augments ecto-ATP diphosphohydrolase activity and enhances endothelial anti-platelet function in human umbilical vein endothelial cells

  2003cites this paper
• Age-related endothelial dysfunction : potential implications for pharmacotherapy.

  2003cites this paper
• ACE inhibition may decrease diabetes risk by boosting the impact of bradykinin on adipocytes.

  2003cites this paper
• New strategies for prevention of ischemic stroke: The life study

  2003cites this paper
• Angiotensin Converting Enzyme Inhibitors After and During Acute Coronary Syndromes, and, in Particular, Myocardial Infarction

  2003cites this paper
• Age-Related Endothelial Dysfunction

  2003cites this paper
• NITRIC OXIDE: AN ENDOGENOUS GAS WITH PLEIOTROPIC ACTIVITIES EMPHASIS ON THE CARDIOVASCULAR SYSTEM

  2003cites this paper
• Can Angiotensin-converting Enzyme Inhibitors Reverse Atherosclerosis?

  2003cites this paper
• The First Hypertension Trial Comparing the Effects of Two Fixed‐Dose Combination Therapy Regimens on Cardiovascular Events: Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH)

  2003cites this paper
• An AT1-Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor Protect Against Hypoxia-Induced Apoptosis in Human Aortic Endothelial Cells Through Upregulation of Endothelial Cell Nitric Oxide Synthase Activity

  2003cites this paper
• The vulnerable plaque and acute coronary syndromes.

  2002cites this paper
• Angiotensin-converting enzyme 2 is an essential regulator of heart function

  2002cites this paper
• New Aspects on Angiotensin-Converting Enzyme: from Gene to Disease

  2002cites this paper